Why GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two Days

investors.com/news/technology/genedx-stock-american-academy-of-pediatrics-whole-genome-sequencing-whole-exome-sequencing

GeneDx stock jumped again Tuesday after the American Academy of Pediatrics green-lit genetic testing for a larger pool of children.
The post Why GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two Days appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-24 18:25:50.
The Entire Business World on a Single Page. Free to Use →